Literature DB >> 35616854

Recombinant Protein Production in Plants: A Brief Overview of Strengths and Challenges.

Stefan Schillberg1,2, Holger Spiegel3.   

Abstract

The first recombinant proteins were produced in microbes and animal cells cultivated in bioreactors. These systems have become the standard for industrial-scale recombinant protein manufacturing. Later, the production of recombinant proteins was demonstrated in whole plants, which differ morphologically from cell-based systems and require completely different cultivation conditions. Over time, additional plant-based production platforms were established, including hairy roots and cell suspension cultures, which are more similar to conventional cell-based systems in terms of morphology, procedures, and equipment requirements. In this brief overview of the field, we explain why plant-based systems are becoming increasingly attractive for the production of valuable proteins with scientific and commercial applications, but also highlight the challenges that these systems must overcome to achieve more widespread industrial utilization. We discuss various laboratory protocols and approaches for the production of recombinant proteins in plants, as well as strategies to optimize yields, and the regulatory and legal framework.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biopharmaceuticals; Downstream processing; Molecular farming products; Optimization strategies; Plant molecular farming; Plant-based expression systems

Mesh:

Substances:

Year:  2022        PMID: 35616854     DOI: 10.1007/978-1-0716-2241-4_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Production of correctly processed human serum albumin in transgenic plants.

Authors:  P C Sijmons; B M Dekker; B Schrammeijer; T C Verwoerd; P J van den Elzen; A Hoekema
Journal:  Biotechnology (N Y)       Date:  1990-03

Review 2.  Plant molecular farming for the production of valuable proteins - Critical evaluation of achievements and future challenges.

Authors:  Stefan Schillberg; Ricarda Finnern
Journal:  J Plant Physiol       Date:  2021-01-05       Impact factor: 3.549

Review 3.  Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures.

Authors:  Stefan Schillberg; Nicole Raven; Rainer Fischer; Richard M Twyman; Andreas Schiermeyer
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

4.  Production of antibodies in transgenic plants.

Authors:  A Hiatt; R Cafferkey; K Bowdish
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

5.  Comprehensive characterization of two different Nicotiana tabacum cell lines leads to doubled GFP and HA protein production by media optimization.

Authors:  David A Ullisch; Christina A Müller; Sabrina Maibaum; Janina Kirchhoff; Andreas Schiermeyer; Stefan Schillberg; Jean L Roberts; Wiltrud Treffenfeldt; Jochen Büchs
Journal:  J Biosci Bioeng       Date:  2011-11-04       Impact factor: 2.894

6.  Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems-The taliglucerase alfa story.

Authors:  Bonita Rup; Sari Alon; Bat-Chen Amit-Cohen; Einat Brill Almon; Raul Chertkoff; Yoram Tekoah; Pauline M Rudd
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

7.  Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins.

Authors:  Stefan Schillberg; Nicole Raven; Holger Spiegel; Stefan Rasche; Matthias Buntru
Journal:  Front Plant Sci       Date:  2019-06-11       Impact factor: 5.753

8.  Application of a Scalable Plant Transient Gene Expression Platform for Malaria Vaccine Development.

Authors:  Holger Spiegel; Alexander Boes; Nadja Voepel; Veronique Beiss; Gueven Edgue; Thomas Rademacher; Markus Sack; Stefan Schillberg; Andreas Reimann; Rainer Fischer
Journal:  Front Plant Sci       Date:  2015-12-23       Impact factor: 5.753

Review 9.  Potential Applications of Plant Biotechnology against SARS-CoV-2.

Authors:  Teresa Capell; Richard M Twyman; Victoria Armario-Najera; Julian K-C Ma; Stefan Schillberg; Paul Christou
Journal:  Trends Plant Sci       Date:  2020-04-24       Impact factor: 18.313

  9 in total
  1 in total

1.  Expression of an extremophilic xylanase in Nicotiana benthamiana and its use for the production of prebiotic xylooligosaccharides.

Authors:  David Talens-Perales; María Nicolau-Sanus; Julio Polaina; José-Antonio Daròs
Journal:  Sci Rep       Date:  2022-09-21       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.